Patients with PD-L1 CPS negative expression had significantly longer OS (median OS NR vs 11.8 months; HR 0.20 95% CI 0.05–0.80 log rank p = 0.024) compared to those whose tumor express PD-L1 CPS ≥ 1. This evidence concerns the gene CD274 and neoplasm.